Latest News for: ironwood pharmaceuticals
Edit
Statement of Changes in Beneficial Ownership (Form 4) (Ironwood Pharmaceuticals Inc)
Public Technologies 13 Aug 2025
) FORM 4. Check this box if no longer subject to Section 16 ... See Instruction 1(b) ... IRONWOOD PHARMACEUTICALS INC [IRWD] 5 ... C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300 3 ... C/O IRONWOOD PHARMACEUTICALS, INC ... Ironwood Pharmaceuticals Inc.
Edit
Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q) (Ironwood Pharmaceuticals Inc)
Public Technologies 11 Aug 2025
We have strategic partnerships with leading pharmaceutical companies to support the development and ... On April 7, 2008, we changed our name to Ironwood Pharmaceuticals, Inc ... Ironwood Pharmaceuticals Inc.
Edit
The Galveston Daily News
08 Aug 2025
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
The Galveston Daily News
08 Aug 2025
Edit
Notice of Proposed Sale of Securities (Form 144) (Ironwood Pharmaceuticals Inc)
Public Technologies 08 Aug 2025
). The text version of this document is not available ... Ironwood Pharmaceuticals Inc.
Edit
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance (Form 8-K) (Ironwood Pharmaceuticals Inc)
Public Technologies 08 Aug 2025
Edit
Second Quarter 2025 Ironwood 2Q 2025 Update (Ironwood Pharmaceuticals Inc)
Public Technologies 08 Aug 2025
) Ironwood Pharmaceuticals ... net sales guidance of $800 - $850 million and Ironwood revenue guidance of $260 - $290 million ... AbbVie & Ironwood commercial costs, expenses and other discounts3 ... Total Ironwood Revenues ... Ironwood Pharmaceuticals Inc.
Edit
Change in Certifying Accountants (Form 8-K) (Ironwood Pharmaceuticals Inc)
Public Technologies 10 Jul 2025
). Item 4.01 Changes in Registrant's Certifying Accountant ... On July 3, 2025, the Audit Committee (the "Audit Committee") of the Board of Directors of Ironwood Pharmaceuticals, Inc ... Disclaimer. Ironwood Pharmaceuticals Inc ... (noodl. 125321131) .
Edit
Proxy Results (Form 8-K) (Ironwood Pharmaceuticals Inc)
Public Technologies 12 Jun 2025
). Item 5.07 Submission of Matters to a Vote of Security Holders. On June 10, 2025, Ironwood Pharmaceuticals, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting") ... 1 ... 2 ... Ironwood Pharmaceuticals Inc.
Edit
Failure to Satisfy Listing Rule (Form 8-K) (Ironwood Pharmaceuticals Inc)
Public Technologies 03 Jun 2025
). Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 28, 2025, Ironwood Pharmaceuticals, Inc ... Attachments Original document Permalink. Disclaimer. Ironwood Pharmaceuticals Inc ... (noodl.
Edit
Quarterly Report for Quarter Ending March 31, 2025 (Form 10-Q) (Ironwood Pharmaceuticals Inc)
Public Technologies 12 May 2025
... 31, 2025 include the accounts of Ironwood, its wholly-owned subsidiaries, Ironwood Pharmaceuticals Securities Corporation, Ironwood Pharmaceuticals GmbH, VectivBio AG, and GlyPharma Therapeutic Inc.
- 1